|本期目录/Table of Contents|

[1]刘 蕊.MDR1启动子的活性研究[J].天津医科大学学报,2017,23(01):28-31.
 LIU Rui.Research on the activity of MDR1 promoter[J].Journal of Tianjin Medical University,2017,23(01):28-31.
点击复制

MDR1启动子的活性研究(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23卷
期数:
2017年01期
页码:
28-31
栏目:
基础医学
出版日期:
2017-01-16

文章信息/Info

Title:
Research on the activity of MDR1 promoter
文章编号:
1006-8147(2017)01-0028-04
作者:
刘 蕊
(天津医科大学第二医院药剂科,天津300211)
Author(s):
LIU Rui
(Department of Pharmacy, The Second Hospital, Tianjin Medical University, Tianjin 300211,China)
关键词:
多药耐药基因-1启动子荧光素酶报告基因活性鉴定
Keywords:
MDR1 promoter luciferase reporter gene detection of activity
分类号:
R965
DOI:
-
文献标志码:
A
摘要:
目的:克隆编码多药耐药基因-1(MDR1)中不同长度的启动子片段并探讨和比较其在乳腺癌细胞中的转录活性。方法: 利用PCR扩增技术以MCF-7/ADR细胞基因组为模板克隆3种不同长度的启动子片段。pGL3-basic的启动区域中,构建一系列报告基因载体pGL3-MDR1Pn。以pGL3-control为阳性对照,分别将含不同长度的MDR1启动子的报告基因载体pGL3-MDR1Pn与pRL-TK以一定比例共转染到敏感的MCF-7细胞和耐阿霉素的MCF-7/ADR细胞,通过分析表达的荧光素酶的活性从而比较不同长度的启动子片段在这两种细胞中的转录活性。结果:通过酶切鉴定和测序验证了已将不同长度的MDR1启动子片段成功插入到荧光素酶报告基因载体pGL3-basic中,且克隆的片段中没有出现碱基突变。将表达载体转染细胞后活性检测结果显示pGL3-MDR1P1、pGL3-MDR1P2和pGL3-MDR1P3在MCF-7中活性分别为阳性对照的(13.03 2.35)%、(14.60 3.57)%和(10.27 1.89)%;而在MCF-7/ADR中活性分别为阳性对照的(105.26 6.84)%、(59.08 4.95)%和(62.39 5.76)%。结论:成功克隆了MDR1启动子片段,并成功构建了荧光素酶报告基因载体pGL3-MDR1P。启动子的活性分析结果初步表明长度约为2 000 bp的MDR1P1在MCF-7/ADR中具有相对较高的特异性。
Abstract:
Objective: To clone different lengths of promoter from multi-drug resistance gene 1 and analysis its activities in MCF-7 cells or MCF-7/ADR cells. Methods: According to a review about the transcriptional regulation to human multi-drug resistance gene 1, three fragments of MDR1 promoter from MCF-7/ADR cell were amplified by PCR, and then they

作者简介 刘蕊(1989-),女,药师,学士,研究方向:临床药学; E-mail:Li351227007@163.com

were inserted into pGL3-basic, a luciferase reporter gene vector, to construct pGL3-MDR1Pn which were directed by MDR1 promoter. The different lengths of MDR1 promoter reporter gene vector pGL3-MDR1Pn and pRL-TK were co-transfected into MCF-7 cells or MCF-7/ADR cells in a certain proportion, where pGL3-control was a positive control. The transcriptional activity of MDR1 promoter at three different lengths in the two kinds of cells were compared by the luciferase activity. Results: The constructions of pGL3-MDR1Pn were determined by DNA sequencing. Compared with the positive control, the activities of pGL3-MDR1P1, pGL3-MDR1P2 and pGL3-MDR1P3 in MCF-7 were (13.03 2.35)%, (14.60 3.57)% and (10.27 1.89)%, respectively. But their activities in MCF-7/ADR were (105.26 6.84)%, (59.08 4.95)% and (62.39 5.76)%, respectively. Conclusion: The MDR1 promoter is cloned successfully and the luciferase reporter gene vectors pGL3-MDR1P are successfully constructed. These results show that MDR1P1 with 2000 bp may have higher specificity in MCF-7/ADR cells than that in MCF-7 cells.

参考文献/References:

[1]王清,刘倩,张学梅. P- 糖蛋白及其逆转肿瘤细胞多药耐药性的研究进展[J].中国执业药师,2013,10(3):33

[2]Binkha Thlan Z,LavasaNIFAR A. P - glycoprotein inhibitionas a therapeutic approach for overcoming multidrug resistancein cancer: current status and future perspectives[J].Curr Cancer Drug Targets,2013,13(3) : 326

[3]Wang X M, Li L, Cui Q, et al. Quantitative detection of peripheral MDR genes in breast cancer before chemotherapy and their clinical significances[J]. Chinese-German J Clinical Oncol , 2008,11(7):641

[4]王向玲,纪春岩,马道新,等. MDR1启动子驱动的CD-TK双自杀基因载体对耐药K562细胞的体外靶向杀伤作用[J].中华血液学杂志,2006,27(11):757

[5]王波,王志云,王成伟,等. MDR1启动子调控的双自杀基因靶向杀伤耐药胶质瘤细胞的研究[J].山东大学学报,2008,46(1):15

[6] Labialle S, Gayet L, Marthinet E, , et al. Transcriptional regulators of the human multidrug resistance 1 gene,recent views[J]. Biochem Pharmacol ,2002,64(5/6):943

[7]贺赛,孙学军,郑见宝,等. hTERT,CEA 及CMV 启动子在人结肠癌细胞株中

的转录活性比较[J]. 中国普通外科杂志,2014,23(1):78

[8]林燕真,程通,张雅丽,等. 肿瘤细胞特异启动子hTERT介导的靶向MDR1基因的RNAi用于逆转卵巢癌细胞MDR的研究[J].中国医学创新,2015,12(34):9

[9]Ogretmen B, Ahmad R S. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region [J]. Biochemistry,1999,38(7):2189

[10]李长龙,萨晓婴. MDR1基因单靶点双荧光素酶报告基因系统的建立[J].中国比较医学杂志,2008,18(9):28

[11]Tesshi Yamada,Asako S T,Yasuyoshi Naishiro, et al. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in earlycolorectal carcinogenesis[J]. Cancer Res. 2000, 60(17):4761

[12]李海平,高波,余宗涛. MDR1基因的表达与肝癌生物学行为指标的关系[J].现代肿瘤医学,2013,21(1):129

[13]况守龙,胡廷章.启动子的克隆和研究方法[J].重庆工学院学报,2007,21(1):136

[14]Greer L F 3rd, Szalay A A. Imaging of light emission from the expression of luciferases in living cells and organisms: a review[J]. Luminescence, 2002,17(1):43

[15]吴胜昔,陈永文,朱广倍,等.B7-H1启动子荧光素酶报告基因载体的构建及活性检测[J].基础医学与临床,2014,34(7):957

相似文献/References:

备注/Memo

备注/Memo:
作者简介 刘蕊(1989-),女,药师,学士,研究方向:临床药学; E-mail:Li351227007@163.com
更新日期/Last Update: 2017-01-16